Based on clinical trials, with the use of GLP-1 medications and lifestyle adjustments, patients can anticipate losing 10-18% of their body weight (based on the average weight loss in three 68 week clinical trials)
Patients with advanced, uncontrolled type 2 diabetes on insulin For patients with advanced, uncontrolled type 2 diabetes who were already on insulin therapy, both oral and injection semaglutide showed significant reductions in HbA1c levels
Ashwagandha has natural sedative and blood-pressure-lowering properties
MeAgain lets you log shots, meals, water, and a customizable side-effect severity slider in under 60 seconds a day, then surfaces the correlation back to you (and to your clinician, if you choose to share it)
I was very impressed with the findings, the details for each, and all the other little things I could dive into